Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alexza Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review Finds
Alexza Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review Finds
Alexza Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review Finds
Submitted by
admin
on December 8, 2011 - 11:22am
Source:
Bloomberg
News Tags:
Alexza
antipsychotics
FDA
Adasuve
Headline:
Alexza Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review Finds
Do Not Allow Advertisers to Use My Personal information
